Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Sarah Tasian

Sarah Tasian

Children's Hospital of Philadelphia
Precision medicine in pediatric ALL 1:09
Precision medicine in pediatric ALL
Sarah Tasian • 4 Jun 2023
Pediatric leukemia at ASCO 2023 1:16
Pediatric leukemia at ASCO 2023
Sarah Tasian • 4 Jun 2023
Improving therapeutic approaches for patients with Ph-like ALL & the importance of disease biology 0:56
Improving therapeutic approaches for patients with Ph-like ALL & the importance of disease biology
Sarah Tasian • 16 Apr 2023
Exploring the potential role of immunotherapy in Ph-like ALL and novel targets of interest 0:42
Exploring the potential role of immunotherapy in Ph-like ALL and novel targets of interest
Sarah Tasian • 16 Apr 2023
Clinical responses of pediatric patients with R/R acute leukemia treated with aza/ven 0:54
Clinical responses of pediatric patients with R/R acute leukemia treated with aza/ven
Sarah Tasian • 16 Apr 2023
Pre-clinical activity of ziftomenib in pediatric KMT2A-rearranged ALL 1:09
Pre-clinical activity of ziftomenib in pediatric KMT2A-rearranged ALL
Sarah Tasian • 10 Dec 2022
Azacitidine and venetoclax +/- gemtuzumab ozogamicin in pediatric patients with R/R acute leukemias 1:23
Azacitidine and venetoclax +/- gemtuzumab ozogamicin in pediatric patients with R/R acute leukemias
Sarah Tasian • 10 Dec 2022
A Phase II study of ruxolitinib with chemotherapy in pediatric patients with Ph-like ALL 1:08
A Phase II study of ruxolitinib with chemotherapy in pediatric patients with Ph-like ALL
Sarah Tasian • 10 Dec 2022
Clinical screening for Ph-like ALL and trials available to pediatric patients 1:00
Clinical screening for Ph-like ALL and trials available to pediatric patients
Sarah Tasian • 10 Dec 2022
Exploring novel treatment strategies for Ph-like ALL 0:49
Exploring novel treatment strategies for Ph-like ALL
Sarah Tasian • 10 Dec 2022
An update on targeted therapy in pediatric leukemia 0:46
An update on targeted therapy in pediatric leukemia
Sarah Tasian • 10 Dec 2022
Gilteritinib and CAR T-cell therapy in high-risk pediatric leukemias 0:49
Gilteritinib and CAR T-cell therapy in high-risk pediatric leukemias
Sarah Tasian • 13 Dec 2021
Targeting TCF3-HLF−positive ALL 1:06
Targeting TCF3-HLF−positive ALL
Sarah Tasian • 13 Dec 2021
Targeting TSLPR in Ph-like and Down syndrome-associated ALL 2:09
Targeting TSLPR in Ph-like and Down syndrome-associated ALL
Sarah Tasian • 13 Dec 2021
Challenges in treating pediatric leukemias 1:06
Challenges in treating pediatric leukemias
Sarah Tasian • 13 Dec 2021
Diagnostic testing modalities for Ph-like ALL 3:08
Diagnostic testing modalities for Ph-like ALL
Sarah Tasian • 13 May 2021
The content of VJHemOnc is intended for healthcare professionals